Prostate cancer: Molecular imaging and MRI
Authors:
- 1 October 2021
- journal article
- research article
- Published by Elsevier in European Journal of Radiology
- Vol. 143, 109893
Abstract
No abstract availableKeywords
This publication has 175 references indexed in Scilit:
- Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysisEuropean Urology, 2013
- Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate CancerClinical Nuclear Medicine, 2012
- Diagnostic value of whole‐body magnetic resonance imaging for bone metastases: a systematic review and meta‐analysisJournal of Magnetic Resonance Imaging, 2011
- Lead-time in the European Randomised Study of Screening for Prostate CancerEuropean Journal of Cancer, 2010
- Nomogram Predicting the Probability of Early Recurrence After Radical Prostatectomy for Prostate CancerJournal of Urology, 2009
- Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence TrendsBiometrics, 2008
- Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cellsNuclear Medicine and Biology, 2006
- Assessing risk: does this patient have prostate cancer?JNCI: Journal of the National Cancer Institute, 2006
- Radiolabeled choline as a proliferation marker: Comparison with radiolabeled acetateNuclear Medicine and Biology, 2004
- Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: A novel folate hydrolaseUrology, 1997